Related Experiment Video

Updated: Oct 29, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K

Percutaneous left atrial appendage closure in the presence of thrombus: the safer, the better

Francisco Torres-Saura1, Ignacio Cruz-González2, Ernesto Raúl Centurión-Inda3

  • 1Unidad de Cardiología Intervencionista, Hospital Universitario de Vinalopó, Elche, Alicante, Spain; Unidad de Cardiología Intervencionista, Hospital Universitario de Torrevieja, Torrevieja, Alicante, Spain.

Revista Espanola De Cardiologia (English Ed.)
|July 12, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.0K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K

Related Experiment Videos

Last Updated: Oct 29, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.6K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.0K
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.8K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

72
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
72
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

290
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
290

Articles linked to this work by shared authors, journal, and citation graph.

Natural Missplicing Events Amplified by an Elusive Deep-Intronic MYBPC3 Variant Cause Hypertrophic Cardiomyopathy.

Circulation·2026

Impact of Tricuspid Regurgitation on Outcomes After Transcatheter Edge-to-Edge Repair for Primary Mitral Regurgitation: The PRIME-MR Registry.

Circulation. Cardiovascular interventions·2026

Multimodality imaging for pre-, intra-, and postprocedural guidance of left atrial appendage closure: a European Left Atrial Appendage Closure Club (ELAACC) expert consensus statement.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Outcomes of patients with large anatomies undergoing transcatheter tricuspid valve replacement with the LuX-Valve Plus system.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

Outcomes of left atrial appendage closure in patients with prior mitral valve interventions.

Clinical research in cardiology : official journal of the German Cardiac Society·2026

Standardized endpoint definitions for trials of transcatheter left atrial appendage closure: a consensus from the Left Atrial Appendage Academic Research Consortium†.

European heart journal·2026

Effect of low-flow, very low-gradient aortic stenosis on survival and objective functional recovery after TAVI.

Revista espanola de cardiologia (English ed.)·2026

Percutaneous left atrial appendage occlusion versus oral anticoagulation in patients with atrial fibrillation: a systematic review and meta-analysis.

Revista espanola de cardiologia (English ed.)·2026

Gray zone NT-proBNP values and long-term outcomes in emergency department patients without prior heart failure.

Revista espanola de cardiologia (English ed.)·2026

Spanish pacemaker registry. 23rd official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2025).

Revista espanola de cardiologia (English ed.)·2026

Spanish implantable cardioverter-defibrillator registry. 22nd official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2025).

Revista espanola de cardiologia (English ed.)·2026

Spanish founder variant in MYBPC3: implications of diagnostic criteria, clinical phenotype, and prognosis.

Revista espanola de cardiologia (English ed.)·2026

Prolonged low-dose intravenous thrombolysis in early recurrent stroke.

Neurologia i neurochirurgia polska·2026

HLA-DRB1 Polymorphisms Modulate the Dynamic Compatibility between the Presentation of EBNA1400-413 and MBP85-99.

ACS omega·2026

Quantification of blood-based neurovascular unit biomarkers: an analytical platform comparison study.

Resuscitation plus·2026

HBsAg seroclearance with HBV DNA <100 IU/mL and long-term risks of adverse liver events, all-cause mortality, and cause-specific mortality in chronic hepatitis B: a prospective cohort study.

The Lancet regional health. Western Pacific·2026

Cost-effectiveness and budget impact of Luspatercept in Thai adults with transfusion-dependent beta-thalassaemia: a multi-state Markov model based on national claims data.

Journal of pharmaceutical policy and practice·2026

Unraveling the Cause of Hemolytic Anemia in the Emergency Department: A Destructive Path.

Cureus·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us